Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Pulmonary Hypertension

Free Subscription 04.09.2023 2 Am J Cardiol 1 Am J Perinatol 1 Am J Physiol Lung Cell Mol Physiol 1 Biology (Basel) 1 BMC Pediatr 1 BMC Pulm Med 1 Br J Hosp Med (Lond) 1 Cardiol Young 1 Cardiorenal Med 1 Children (Basel) 1 Cureus 1 Curr Cardiol Rep 1 Diagnostics (Basel) 1 Egypt Heart J 2 Eur Heart J Cardiovasc Imaging 1 Eur Heart J Case Rep 1 Eur J Obstet Gynecol Reprod Biol 1 Eur J Pharmacol 1 Front Neurosci 1 Front Pharmacol 1 Front Physiol 1 Int J Cardiol 2 Int J Mol Sci 2 J Cardiovasc Dev Dis 1 J Cardiovasc Pharmacol 1 J Cardiovasc Transl Res 1 J Heart Lung Transplant 1 J Pediatr 1 J Perinatol 1 J Pharmacol Sci 1 Medicina (Kaunas) 1 Obes Surg 1 Patient Prefer Adherence 1 PLoS One 1 Respir Med Res 1 Rev Port Cardiol 1 Zhonghua Yi Xue Yi Chuan Xue Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. ALPERT MA
   Beneficial Effects of Inspiratory Muscle Training in Patients With Pulmonary Arterial Hypertension.
   Am J Cardiol. 2023 Aug 7:S0002-9149(23)00689.
   PubMed        
   
   
2. RZECHORZEK W, Dey S, Shah A, Michaud L, et al
   High-Risk Pulmonary Hypertension Does Not Worsen Outcomes in Heart Transplantation.
   Am J Cardiol. 2023;205:290-297.
   PubMed         Abstract available
   
   

   
   Am J Perinatol

3. WEI Q, Chen W, Liang Q, Song S, et al
   Effect of Endotracheal Suctioning on Infants Born through Meconium-Stained Amniotic Fluid: A Meta-Analysis.
   Am J Perinatol. 2022 Jan 11. doi: 10.1055/s-0041-1741034.
   PubMed         Abstract available
   
   

   
   Am J Physiol Lung Cell Mol Physiol

4. ALMAZROUE H, Jin Y, Nelin LD, Barba JC 2nd, et al
   Human pulmonary microvascular endothelial cell DDAH1-mediated nitric oxide production promotes pulmonary smooth muscle cell apoptosis in co-culture.
   Am J Physiol Lung Cell Mol Physiol. 2023;325:L360-L367.
   PubMed         Abstract available
   
   

   
   Biology (Basel)

5. CONTI M, Minniti M, Tine M, De Francesco M, et al
   Extracellular Vesicles in Pulmonary Hypertension: A Dangerous Liaison?
   Biology (Basel). 2023;12:1099.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

6. DENG XX, Jin BW, Li SS, Zhou HM, et al
   Pulmonary hypertension- a novel phenotypic hypothesis of Kabuki syndrome: a case report and literature review.
   BMC Pediatr. 2023;23:429.
   PubMed         Abstract available
   
   

   
   BMC Pulm Med

7. DUAN A, Huang Z, Zhao Z, Zhao Q, et al
   The potential of cystatin C as a predictive biomarker in pulmonary hypertension.
   BMC Pulm Med. 2023;23:311.
   PubMed         Abstract available
   
   

   
   Br J Hosp Med (Lond)

8. TSIAMITA O, White K
   Post-thrombotic syndrome and chronic thromboembolic pulmonary hypertension: diagnosis and management.
   Br J Hosp Med (Lond). 2023;84:1-10.
   PubMed         Abstract available
   
   

   
   Cardiol Young

9. DENIWAR A, Hernandez J, Aregullin EO, Khan SK, et al
   Atrial septal defect-associated pulmonary hypertension with decompensated heart failure: outcomes after fenestrated device closure - CORRIGENDUM.
   Cardiol Young. 2023 Sep 1:1. doi: 10.1017/S1047951123003281.
   PubMed        
   
   

   
   Cardiorenal Med

10. WU H, Huan C, Hu Y, Xiao S, et al
    Development and validation of a nomogram for predicting all-cause mortality in patients with hemodialysis having pulmonary hypertension.
    Cardiorenal Med. 2023 Aug 28. doi: 10.1159/000533674.
    PubMed         Abstract available
    
    

    
    Children (Basel)

11. DILLON K, Lamba V, Philip RR, Weems MF, et al
    Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
    Children (Basel). 2023;10:1397.
    PubMed         Abstract available
    
    

    
    Cureus

12. KERKUTLUOGLU M, Gunes H, Atilla N, Celik E, et al
    Relationship Between Soluble ST2 Level and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) in Acute Pulmonary Embolism (PE) Patients.
    Cureus. 2023;15:e42449.
    PubMed         Abstract available
    
    

    
    Curr Cardiol Rep

13. WOOD KP, Fleming GA, Chamberlain RC
    Update on Transcatheter Device Closure of Congenital Septal Defects.
    Curr Cardiol Rep. 2023;25:1083-1093.
    PubMed         Abstract available
    
    

    
    Diagnostics (Basel)

14. MANDOLI GE, Landra F, Chiantini B, Sciaccaluga C, et al
    Tricuspid Regurgitation Velocity and Mean Pressure Gradient for the Prediction of Pulmonary Hypertension According to the New Hemodynamic Definition.
    Diagnostics (Basel). 2023;13:2619.
    PubMed         Abstract available
    
    

    
    Egypt Heart J

15. DIMITRY MO, Soliman YMA, ElKorashy RI, Raslan HM, et al
    Role of micro-RNAs 21, 124 and other novel biomarkers in distinguishing between group 1 WHO pulmonary hypertension and group 2, 3 WHO pulmonary hypertension.
    Egypt Heart J. 2023;75:76.
    PubMed         Abstract available
    
    

    
    Eur Heart J Cardiovasc Imaging

16. MIZUNO R, Uesugi A, Yamazaki M
    Giant pulmonary artery aneurysm in long-standing chronic thromboembolic pulmonary hypertension.
    Eur Heart J Cardiovasc Imaging. 2023 Aug 29:jead217. doi: 10.1093.
    PubMed        
    
    
17. WANG H, Zhou X, Xiong C
    A rare etiology of pulmonary hypertension-pulmonary tumor thrombotic microangiopathy.
    Eur Heart J Cardiovasc Imaging. 2023 Aug 28:jead219. doi: 10.1093.
    PubMed        
    
    

    
    Eur Heart J Case Rep

18. KURNICK A, Zaveri S, Tadayoni A, Chandrakumar HP, et al
    Reversible severe pulmonary hypertension and right heart failure with cardiogenic shock due to scurvy: a case report.
    Eur Heart J Case Rep. 2023;7:ytad404.
    PubMed         Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

19. WU XC, Ye FL, Zheng XZ
    Fetal pulmonary artery stiffness is a strong predictor of persistent pulmonary hypertension of the newborn - An echocardiographic study.
    Eur J Obstet Gynecol Reprod Biol. 2023;289:60-64.
    PubMed         Abstract available
    
    

    
    Eur J Pharmacol

20. CHAI L, Wang Q, Wang Y, Li D, et al
    Downregulation of PDCD4 through STAT3/ATF6/autophagy mediates MIF-induced PASMCs proliferation/migration and vascular remodeling.
    Eur J Pharmacol. 2023;956:175968.
    PubMed         Abstract available
    
    

    
    Front Neurosci

21. OLIVEIRA AC, Karas MM, Alves M, He J, et al
    ACE2 overexpression in corticotropin-releasing-hormone cells offers protection against pulmonary hypertension.
    Front Neurosci. 2023;17:1223733.
    PubMed         Abstract available
    
    

    
    Front Pharmacol

22. WANG LJ, Feng F, Li JC, Chen TT, et al
    Role of heparanase in pulmonary hypertension.
    Front Pharmacol. 2023;14:1202676.
    PubMed         Abstract available
    
    

    
    Front Physiol

23. GENG Y, Hu Y, Zhang F, Tuo Y, et al
    Mitochondria in hypoxic pulmonary hypertension, roles and the potential targets.
    Front Physiol. 2023;14:1239643.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

24. ZENG X, Wu Z, Cen C, Wen S, et al
    Thrombosis is not the only determinant of chronic thromboembolic pulmonary hypertension.
    Int J Cardiol. 2023 Aug 29:131304. doi: 10.1016/j.ijcard.2023.131304.
    PubMed        
    
    

    
    Int J Mol Sci

25. SANCHEZ-GLORIA JL, Martinez-Olivares CE, Del Valle-Mondragon L, Cortes-Camacho F, et al
    Allicin, an Emerging Treatment for Pulmonary Arterial Hypertension: An Experimental Study.
    Int J Mol Sci. 2023;24:12959.
    PubMed         Abstract available
    
    
26. PULLAMSETTI SS, Sitapara R, Osterhout R, Weiss A, et al
    Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2023;24:12653.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Dev Dis

27. ISHIDA H, Maeda J, Uchida K, Yamagishi H, et al
    Unique Pulmonary Hypertensive Vascular Diseases Associated with Heart and Lung Developmental Defects.
    J Cardiovasc Dev Dis. 2023;10:333.
    PubMed         Abstract available
    
    
28. STERINGER-MASCHERBAUER R, Huber C, Froschl U, Engleder D, et al
    Intravenous Treprostinil in Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension Using Implantable Pumps-Single-Center Experience over More Than a Decade.
    J Cardiovasc Dev Dis. 2023;10:318.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Pharmacol

29. BROCKMOLLER J, Ivanoski S, Hundack L, Blohm JH, et al
    Clinical and hemodynamic improvement in pulmonary hypertension after switching to sacubitril/valsartan in heart failure patients with preserved ejection fraction.
    J Cardiovasc Pharmacol. 2023 Sep 1. doi: 10.1097/FJC.0000000000001477.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Transl Res

30. WU Y, Tian P, Liang L, Chen Y, et al
    Improved Prognostic Performance of Right Atrial Pressure-Corrected Cardiac Power Output in Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction.
    J Cardiovasc Transl Res. 2023 Aug 29. doi: 10.1007/s12265-023-10429.
    PubMed         Abstract available
    
    

    
    J Heart Lung Transplant

31. YE JR, Hu SY, Lin YH, Huang CH, et al
    Surgery for fibrosing mediastinitis with severe pulmonary hypertension due to pulmonary venous stenosis.
    J Heart Lung Transplant. 2023 Aug 25:S1053-2498(23)02002.
    PubMed         Abstract available
    
    

    
    J Pediatr

32. SFERRA SR, Guo M, Gonzalez Salazar AJ, Penikis AB, et al
    Sex-specific Differences in Congenital Diaphragmatic Hernia Mortality.
    J Pediatr. 2023 May 15:113481. doi: 10.1016/j.jpeds.2023.113481.
    PubMed         Abstract available
    
    

    
    J Perinatol

33. TIMBERLINE S, Bhatt A, Sunderji S, Tancredi DJ, et al
    Novel scoring tool of hypoxemic respiratory failure and pulmonary hypertension for defining severity of persistent pulmonary hypertension of newborn.
    J Perinatol. 2023 Aug 25. doi: 10.1038/s41372-023-01762.
    PubMed         Abstract available
    
    

    
    J Pharmacol Sci

34. ISHIDA M, Yamamura A, Fujiwara M, Amano T, et al
    Pimaric acid reduces vasoconstriction via BK(Ca) channel activation and VDCC inhibition in rat pulmonary arterial smooth muscles.
    J Pharmacol Sci. 2023;153:84-88.
    PubMed         Abstract available
    
    

    
    Medicina (Kaunas)

35. KAULINS R, Rudzitis A, Lejnieks A, Kigitovica D, et al
    Baseline Clinical Characteristics and Incidence of Chronic Thromboembolic Pulmonary Hypertension Patients in Latvia, 2019-2020.
    Medicina (Kaunas). 2023;59:1426.
    PubMed         Abstract available
    
    

    
    Obes Surg

36. ESPARHAM A, Shoar S, Mehri A, Modukuru VR, et al
    Bariatric Surgery and Cardiovascular Disease Risk in Patients with Pulmonary Hypertension: A Propensity Score Matched Analysis of US National Inpatient Sample.
    Obes Surg. 2023 Aug 28. doi: 10.1007/s11695-023-06799.
    PubMed         Abstract available
    
    

    
    Patient Prefer Adherence

37. NAFEES B, de Freitas HM, Beaudet A, Todd E, et al
    A Health State Utility Study to Elicit Societal Values Associated with Pulmonary Hypertension.
    Patient Prefer Adherence. 2023;17:2119-2130.
    PubMed         Abstract available
    
    

    
    PLoS One

38. RAMBARAT P, Zern EK, Wang D, Roshandelpoor A, et al
    Identifying high risk clinical phenogroups of pulmonary hypertension through a clustering analysis.
    PLoS One. 2023;18:e0290553.
    PubMed         Abstract available
    
    

    
    Respir Med Res

39. MARTIN G, Canuet M, Rahli M, Schuller A, et al
    Severe pre-capillary pulmonary hypertension associated with kyphoscoliosis: Description of 4 cases.
    Respir Med Res. 2023;84:101034.
    PubMed        
    
    

    
    Rev Port Cardiol

40. PARGANA J, Cale R, Martinho M, Santos J, et al
    Prevalence and predictors of chronic thromboembolic pulmonary hypertension following severe forms of acute pulmonary embolism.
    Rev Port Cardiol. 2023 Aug 29:S0870-2551(23)00392.
    PubMed        
    
    

    
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi

41. ZHANG W, Liu Z, Lin W, Zhang F, et al
    [Diagnosis and treatment of a child with alveolar capillary dysplasia with misalignment of pulmonary veins due to variant of FOXF1 gene].
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2023;40:1171-1175.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: